BioMarin Pharmaceutical Inc. (BMRN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
93.89-1.06 (-1.12%)
At close: 4:00 PM EDT

93.89 0.00 (0.00%)
After hours: 4:48 PM EDT

People also watch:
ALXNREGNVRTXMDVNINCY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open95.29
Prev Close94.95
Bid93.26 x 100
Ask96.00 x 200
Day's Range93.02 - 95.95
52wk Range62.12 - 134.71
1y Target EstN/A
Market Cap16.03B
P/E Ratio (ttm)-28.56
Beta1.65
Volume896,588
Avg Vol (3m)1,906,541
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Barrons.com8 hours ago

    Biotech: In Unfamiliar Territory?

    Once high-flying biotech stocks like Gilead Sciences (GILD), Celgene (CELG), Regeneron Pharmaceuticals (REGN) and BioMarin  (BMRN) have had a tough time during the past 12 months. S&P Global Market Intelligence's Jeffrey Loo sees better times ahead: After the significant outperformance of the biotechnology industry in recent years, 2016 placed biotech investors in unfamiliar territory. In 2015, the FDA approved 45 new drugs, up from 41 in 2014 and 27 in 2013, and the most since a record 53 were approved in 1996.

  • GlobeNewswire10 hours ago

    BioMarin to Attend Upcoming Investor Conferences

    Citi’ s 11 th Annual Biotech Conference September 7 in Boston. Robert W. Baird & Co. 2016 Global Healthcare Conference September 8 in New York. Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology ...

  • 24/7 Wall St.10 hours ago

    3 Biotech Stocks Could Be the Next Big Takeover Targets

    In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative takeover targets, and a third is a possible target as well.